AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1464164 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal MST administration
Number of subjects: 10
Study 1464164 — intervention group
Group type: COMPARATOR
Intervention: Oral MST administration
Number of subjects: 10
Study 1464164 — intervention group
Group type: COMPARATOR
Intervention: Oral and Rectal MST administration
Number of subjects: 10
Study 6389060 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g glucose with 50 g protein
Number of subjects: 0
Study 6389060 — intervention group
Group type: COMPARATOR
Intervention: 50 g protein alone
Number of subjects: 0
Study 6389060 — intervention group
Group type: COMPARATOR
Intervention: 50 g glucose alone
Number of subjects: 0
Study 6389060 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g glucose with 50 g protein (second meal)
Number of subjects: 0
Study 6389060 — intervention group
Group type: COMPARATOR
Intervention: 50 g glucose (second meal)
Number of subjects: 0
Study 31373418 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 60
Study 31373418 — intervention group
Group type: COMPARATOR
Intervention: Sufentanil
Number of subjects: 60
Study 29335629 — intervention group
Group type: EXPERIMENTAL
Intervention: Exergaming on Nintendo Wii®
Number of subjects: 42
Study 29335629 — intervention group
Group type: COMPARATOR
Intervention: Classical physiotherapy (PT)
Number of subjects: 42
Study 29335629 — intervention group
Group type: COMPARATOR
Intervention: Both groups (Exergaming and PT)
Number of subjects: 42
Study 27428595 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing high-heeled shoes for 2-5 years
Number of subjects: 137
Study 27428595 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing high-heeled shoes for 6-10 years
Number of subjects: 137
Study 27428595 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing high-heeled shoes for >20 years
Number of subjects: 137
Study 27428595 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing high-heeled shoes for <2 years
Number of subjects: 137
Study 27428595 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing high-heeled shoes for 11-20 years
Number of subjects: 137
Study 27428595 — intervention group
Group type: COMPARATOR
Intervention: Control group (no high-heeled shoes)
Number of subjects: 137
Study 24202408 — intervention group
Group type: EXPERIMENTAL
Intervention: MICA-TKA (minimal invasive and computer-assisted technique)
Number of subjects: 80
Study 24202408 — intervention group
Group type: COMPARATOR
Intervention: MI-TKA (minimal invasive technique)
Number of subjects: 80
Study 22144003 — intervention group
Group type: EXPERIMENTAL
Intervention: MENTHOL SPRAY
Number of subjects: 11
Study 22144003 — intervention group
Group type: COMPARATOR
Intervention: CONTROL SPRAY
Number of subjects: 11
Study 22144003 — intervention group
Group type: COMPARATOR
Intervention: CON (no spray)
Number of subjects: 11
Study 22144003 — intervention group
Group type: COMPARATOR
Intervention: CON-SPRAY (control spray)
Number of subjects: 11
Study 20347088 — intervention group
Group type: EXPERIMENTAL
Intervention: 50-microg dose of misoprostol intravaginally 3 hours before oxytocin infusion
Number of subjects: 100
Study 20347088 — intervention group
Group type: COMPARATOR
Intervention: Oxytocin infusion alone
Number of subjects: 100
Study 20347088 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study 16722027 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal intermittent peritoneal dialysis (NIPD)
Number of subjects: 11
Study 16722027 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous cyclic peritoneal dialysis (CCPD)
Number of subjects: 11
Study 16722027 — intervention group
Group type: COMPARATOR
Intervention: Continuous ambulatory peritoneal dialysis (CAPD)
Number of subjects: 11
Study 15218994 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium 18 microg once daily for 42 days
Number of subjects: 187
Study 15218994 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 187
Study 10926790 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg/day I‐3‐C
Number of subjects: 30
Study 10926790 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg/day I‐3‐C
Number of subjects: 30
Study 10926790 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 9315044 — intervention group
Group type: EXPERIMENTAL
Intervention: Permethrin-treated curtains
Number of subjects: 90000
Study 9315044 — intervention group
Group type: EXPERIMENTAL
Intervention: Permethrin-treated curtains (first year)
Number of subjects: 90000
Study 9315044 — intervention group
Group type: EXPERIMENTAL
Intervention: Permethrin-treated curtains (second year)
Number of subjects: 90000
Study 8395713 — intervention group
Group type: EXPERIMENTAL
Intervention: LMWH CY 216 (n = 35), subcutaneous injection, 6 months
Number of subjects: 75
Study 8395713 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 40), no specific treatment
Number of subjects: 75
Study 8395713 — intervention group
Group type: EXPERIMENTAL
Intervention: LMWH CY 216 (n = 15 with preceding cerebral embolism)
Number of subjects: 75
Study 8395713 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 7 with preceding cerebral embolism)
Number of subjects: 75
Study 2944925 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline treatment
Number of subjects: 40
Study 2944925 — intervention group
Group type: COMPARATOR
Intervention: Paykel's Clinical Interview for Depression, Brief Depression Rating Scale, Symptom Questionnaire (SQ)
Number of subjects: 40
Study 2944925 — intervention group
Group type: COMPARATOR
Intervention: Contentment subscale of the SQ
Number of subjects: 40
Study 2944925 — intervention group
Group type: COMPARATOR
Intervention: Depression subscale of the SQ
Number of subjects: 40
Study 30252688 — intervention group
Group type: EXPERIMENTAL
Intervention: Plate expression
Number of subjects: 17
Study 30252688 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital expression
Number of subjects: 17
Study 30252688 — intervention group
Group type: COMPARATOR
Intervention: No expression
Number of subjects: 17
Study 30252688 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (including digital and no expression)
Number of subjects: 17
Study 30252688 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorescein staining score
Number of subjects: 17
Study 28558452 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailor-made notched music therapy
Number of subjects: 43
Study 28558452 — intervention group
Group type: COMPARATOR
Intervention: Analogous sound masking (Control)
Number of subjects: 43
Study 25996425 — intervention group
Group type: EXPERIMENTAL
Intervention: Single session laser photoablation
Number of subjects: 29
Study 25996425 — intervention group
Group type: COMPARATOR
Intervention: Two-session laser photoablation
Number of subjects: 29
Study 23827881 — intervention group
Group type: EXPERIMENTAL
Intervention: Mercury exposure from dental amalgam tooth fillings
Number of subjects: 507
Study 23827881 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic variants of metallothionein (MT1M and MT2A)
Number of subjects: 507
Study 23827881 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary Hg levels
Number of subjects: 507
Study 21235759 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram 10-20 mg/day
Number of subjects: 305
Study 21235759 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 305
Study 21235759 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 305
Study 19873910 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture therapy (Guanyuan (CV 4), Taixi (KI 3), Sanyinjiao (SP 6))
Number of subjects: 60
Study 19873910 — intervention group
Group type: COMPARATOR
Intervention: Control group (antagonist scheme for ovulation induction without electroacupuncture)
Number of subjects: 60
Study 17032148 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid (ZOL) 5 mg infusion
Number of subjects: 296
Study 17032148 — intervention group
Group type: COMPARATOR
Intervention: Risedronate (RIS) 30 mg daily by mouth for 60 days
Number of subjects: 296
Study 17032148 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid (ZOL)
Number of subjects: 296
Study 17032148 — intervention group
Group type: COMPARATOR
Intervention: Risedronate (RIS)
Number of subjects: 296
Study 15863410 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry juice (300 ml daily)
Number of subjects: 376
Study 15863410 — intervention group
Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 376
Study 12410197 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc-fortified ORS (40 mg/L)
Number of subjects: 1219
Study 12410197 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc syrup (15 mg for 6-11 months; 30 mg for 12-35 months)
Number of subjects: 1219
Study 12410197 — intervention group
Group type: COMPARATOR
Intervention: Control (ORS only)
Number of subjects: 1219
Study 9479341 — intervention group
Group type: EXPERIMENTAL
Intervention: ThinPrep Pap Test
Number of subjects: 16314
Study 8789182 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal AV delay pacing
Number of subjects: 19
Study 8789182 — intervention group
Group type: COMPARATOR
Intervention: Worst AV delay pacing
Number of subjects: 19
Study 2196354 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced manipulation protocol (n = 62)
Number of subjects: 156
Study 2196354 — intervention group
Group type: COMPARATOR
Intervention: Standard care (n = 94)
Number of subjects: 156
Study 2196354 — intervention group
Group type: COMPARATOR
Intervention: Standard manipulation
Number of subjects: 156
Study 353085 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol-containing chewing gum
Number of subjects: 18
Study 353085 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose-containing chewing gum
Number of subjects: 18
Study 353085 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 18
Study 29794874 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg BID
Number of subjects: 1216
Study 28747281 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (1-hour sessions twice daily for 10 weeks)
Number of subjects: 52
Study 28747281 — intervention group
Group type: COMPARATOR
Intervention: Sham transcutaneous electrical nerve stimulation (1-hour sessions twice daily for 10 weeks)
Number of subjects: 52
Study 25526227 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily, extended-release hydrocodone (Hysingla™ ER tablets)
Number of subjects: 0
Study 25526227 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 23580378 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted collaborative care intervention
Number of subjects: 0
Study 23580378 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 21653932 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir 400 mg twice a day
Number of subjects: 63
Study 21653932 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 19539380 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracapsular tonsillectomy/tonsillotomy (TT) (n=35)
Number of subjects: 67
Study 19539380 — intervention group
Group type: COMPARATOR
Intervention: Regular tonsillectomy (TE) (n=32)
Number of subjects: 67
Study 19539380 — intervention group
Group type: EXPERIMENTAL
Intervention: Both TT and TE
Number of subjects: 67
Study 16643698 — intervention group
Group type: EXPERIMENTAL
Intervention: TTM-based interventions
Number of subjects: 0
Study 16643698 — intervention group
Group type: COMPARATOR
Intervention: Control arm (standard midwifery advice and self-help leaflet)
Number of subjects: 0
Study 14758575 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine examination
Number of subjects: 85
Study 14758575 — intervention group
Group type: COMPARATOR
Intervention: In-person clinical examination
Number of subjects: 85
Study 11535508 — intervention group
Group type: EXPERIMENTAL
Intervention: FLT3/ITD mutation present
Number of subjects: 854
Study 11535508 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of a mutation
Number of subjects: 854
Study 11535508 — intervention group
Group type: EXPERIMENTAL
Intervention: More than one mutation in FLT3/ITD(+) patients
Number of subjects: 854
Study 11535508 — intervention group
Group type: EXPERIMENTAL
Intervention: Biallelic disease or partial/complete loss of wild-type alleles in FLT3/ITD(+) patients
Number of subjects: 854
Study 9759983 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 50 mg
Number of subjects: 77
Study 9759983 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide 25 mg
Number of subjects: 77
Study 7826829 — intervention group
Group type: EXPERIMENTAL
Intervention: gamma-L-glutamyl-5-hydroxy-L-tryptophan (glu-5-HTP)
Number of subjects: 8
Study 7826829 — intervention group
Group type: EXPERIMENTAL
Intervention: carbidopa (100 mg)
Number of subjects: 8
Study 7826829 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 8
Study 2595518 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured educational intervention
Number of subjects: 340
Study 2595518 — intervention group
Group type: COMPARATOR
Intervention: Standard information according to the clinic protocol
Number of subjects: 340
Study 1038614 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothbrush at four-hour intervals
Number of subjects: 48
Study 1038614 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothbrush at two-hour intervals
Number of subjects: 48
Study 1038614 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothette
Number of subjects: 48
Study 1038614 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothbrush
Number of subjects: 48
Study 31449675 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to the school personnel workshop
Number of subjects: 488
Study 31449675 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to the student curriculum
Number of subjects: 488
Study 31449675 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to the handout
Number of subjects: 488
Study 31449675 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher baseline knowledge and reactive bystander intentions
Number of subjects: 488
Study 31449675 — intervention group
Group type: EXPERIMENTAL
Intervention: Fewer barriers to bystander action
Number of subjects: 488
Study 31449675 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of intervention components
Number of subjects: 488
Study 31449675 — intervention group
Group type: COMPARATOR
Intervention: No intervention components
Number of subjects: 488
Study 30741579 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid maxillary expansion (RME) using Haas/Hyrax expander
Number of subjects: 46
Study 30741579 — intervention group
Group type: COMPARATOR
Intervention: Slow maxillary expansion (SME) using quad-helix appliance
Number of subjects: 46
Study 28662034 — intervention group
Group type: COMPARATOR
Intervention: MA (20 mg Sb+5/kg/day for 20 days)
Number of subjects: 378
Study 28662034 — intervention group
Group type: EXPERIMENTAL
Intervention: LAMB (3 mg/kg/day for 7 days)
Number of subjects: 378
Study 28662034 — intervention group
Group type: EXPERIMENTAL
Intervention: LAMB plus MA (10 mg/kg single dose plus 20 mg Sb+5/kg/day for 10 days)
Number of subjects: 378
Study 28662034 — intervention group
Group type: EXPERIMENTAL
Intervention: AmphoB (1 mg/kg/day for 14 days)
Number of subjects: 378
Study 28662034 — intervention group
Group type: EXPERIMENTAL
Intervention: LAMB
Number of subjects: 378
Study 25628286 — intervention group
Group type: EXPERIMENTAL
Intervention: Open carpal tunnel release with subneural reconstruction of the transverse carpal ligament (n = 68)
Number of subjects: 213
Study 25628286 — intervention group
Group type: COMPARATOR
Intervention: Isolated open carpal tunnel release (n = 92)
Number of subjects: 213
Study 25628286 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic carpal tunnel release (n = 53)
Number of subjects: 213
Study 22551835 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle modification program
Number of subjects: 0
Study 20514956 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam and morphine (group M)
Number of subjects: 90
Study 20514956 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron and morphine (group O)
Number of subjects: 90
Study 20514956 — intervention group
Group type: COMPARATOR
Intervention: Morphine alone (group C)
Number of subjects: 90
Study 18541571 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplements (200 mug as selenomethionine)
Number of subjects: 913
Study 18541571 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 913
Study 15780456 — intervention group
Group type: EXPERIMENTAL
Intervention: Transformed visual feedback (inverted in both vertical and horizontal axes)
Number of subjects: 0
Study 15780456 — intervention group
Group type: EXPERIMENTAL
Intervention: Transformed visual feedback (inverted along a single axis as in a mirror‐inversion)
Number of subjects: 0
Study 15780456 — intervention group
Group type: COMPARATOR
Intervention: Baseline condition (no visual feedback transformation)
Number of subjects: 0
Study 15780456 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptation to visual feedback
Number of subjects: 0
Study 12482332 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination chemotherapy including irinotecan, oxaliplatin, and 5-fluorouracil (5-FU) with leucovorin
Number of subjects: 0
Study 12482332 — intervention group
Group type: COMPARATOR
Intervention: 5-FU-based regimens alone
Number of subjects: 0
Study 10549700 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed Electromagnetic Fields (PEMF)
Number of subjects: 195
Study 10549700 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 195
Study 10549700 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term follow-up
Number of subjects: 195
Study 7728786 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral milrinone 2.5 mg
Number of subjects: 31
Study 7728786 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral milrinone 5 mg
Number of subjects: 31
Study 7728786 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral milrinone 10 mg
Number of subjects: 31
Study 2340612 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal block with 0.5 ml.kg‐1 of bupivacaine 0.25% following induction of anaesthesia before surgery
Number of subjects: 40
Study 2340612 — intervention group
Group type: COMPARATOR
Intervention: Caudal block at the completion of surgery before emergence from general anaesthesia
Number of subjects: 40
Study 7182948 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of butropium bromide (BB) at doses of 10 and 15 mg
Number of subjects: 0
Study 7182948 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular administration of butropium bromide (BB) at doses of 0.25 and 0.5 mg
Number of subjects: 0
Study 7182948 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular administration of butropium bromide (BB) at doses of 0.25-2.0 mg/person
Number of subjects: 0
Study 30590716 — intervention group
Group type: EXPERIMENTAL
Intervention: ACEi/ARBs
Number of subjects: 13741
Study 30590716 — intervention group
Group type: EXPERIMENTAL
Intervention: β-blockers
Number of subjects: 13741
Study 30590716 — intervention group
Group type: EXPERIMENTAL
Intervention: ACEi/ARBs + β-blockers
Number of subjects: 13741
Study 30590716 — intervention group
Group type: COMPARATOR
Intervention: Matched controls without antihypertensive treatment
Number of subjects: 13741
Study 28189123 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyproterone acetate (CPA) 10 mg/20 mg
Number of subjects: 56
Study 28189123 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel (LNG) 120 μg/240 μg
Number of subjects: 56
Study 28189123 — intervention group
Group type: EXPERIMENTAL
Intervention: Norethisterone acetate (NETA) 5 mg/10 mg
Number of subjects: 56
Study 28189123 — intervention group
Group type: EXPERIMENTAL
Intervention: Nestorone® (NES) 2 mg/3 mg
Number of subjects: 56
Study 28189123 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal testosterone (T)
Number of subjects: 56
Study 28189123 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of progestins with transdermal testosterone
Number of subjects: 56
Study 28189123 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (CPA, LNG, NETA, NES)
Number of subjects: 56
Study 26472098 — intervention group
Group type: EXPERIMENTAL
Intervention: Azelaic acid
Number of subjects: 32
Study 26472098 — intervention group
Group type: COMPARATOR
Intervention: Combined oral contraceptive
Number of subjects: 32
Study 23378537 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard therapy with educational materials (EMs)
Number of subjects: 4844
Study 23378537 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 4844
Study 21088596 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective OLV with tidal volume 6 ml/kg, FIO2 of 0.5, PEEP of 5 cmH2O
Number of subjects: 49
Study 21088596 — intervention group
Group type: COMPARATOR
Intervention: Conventional OLV with tidal volume 10 ml/kg, FIO2 of 1.0, no PEEP
Number of subjects: 49
Study 19552728 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibandronate 6 mg intravenous every 4 weeks for 24 months
Number of subjects: 150
Study 19552728 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 19552728 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibandronate
Number of subjects: 150
Study 17325898 — intervention group
Group type: EXPERIMENTAL
Intervention: P-VEBEC
Number of subjects: 232
Study 17325898 — intervention group
Group type: COMPARATOR
Intervention: Mini-CEOP
Number of subjects: 232
Study 16448299 — intervention group
Group type: EXPERIMENTAL
Intervention: Contextual factors (physicians' ages, race-ethnicities, patient race-ethnicity, office-related barriers)
Number of subjects: 235
Study 16448299 — intervention group
Group type: EXPERIMENTAL
Intervention: Theoretical predictors from the theory of planned behavior, social-cognitive theory, and the transtheoretical model
Number of subjects: 235
Study 12900686 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate (CHO) ingestion (6.4%, 64 g x L‐1)
Number of subjects: 9
Study 12900686 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA) beverage ingestion
Number of subjects: 9
Study 10870740 — intervention group
Group type: EXPERIMENTAL
Intervention: Older generation antidepressants (e.g., amitriptyline, nortriptyline)
Number of subjects: 0
Study 10870740 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticonvulsant (e.g., gabapentin)
Number of subjects: 0